Perinatal mortality in Type 2 DM is significantly increased, mainly owing to an excess of late fetal death. Maternal factors such as obesity may be important contributors to the high perinatal mortality. Women diagnosed with GDM who have unrecognized Type 2 DM are also at high risk, but perinatal mortality is low in women with milder degrees of glucose intolerance in pregnancy.
Aims In many parts of the world the number of pregnancies in women with Type 2 diabetes mellitus (DM) now exceeds that in women with Type 1 DM, but there are few data published on perinatal mortality in Type 2 DM. This study reports observational data on perinatal mortality in Type 2 DM from a population with a high background rate of this disorder.Methods Over a 12-year period (1985±1997) at the Diabetes Clinic at National Women's Hospital, Auckland, there were 434 pregnancies in women with Type 2 DM (256 known and 178 diagnosed with gestational diabetes mellitus (GDM), but con®rmed to have Type 2 DM early post-partum), 160 pregnancies in women with Type 1 DM and 932 in women with GDM. Perinatal mortality was classi®ed as either intermediate fetal death (20± 28 weeks' gestation), late fetal death (28 weeks' gestation to term) or early neonatal death (up to 1 month post-partum). ResultsThe perinatal mortality in Type 2 DM was 46.1/1000, signi®cantly higher than the rates for the general population (12.5), Type 1 DM (12.5) and GDM (8.9) (P < 0.0001). Congenital malformations accounted for only 10% of the perinatal mortality. There was a seven-fold increase in the rate of late fetal death and 2.5-fold increase in the rates of intermediate fetal and late neonatal death. Subjects with Type 2 DM were signi®cantly older and more obese than subjects with Type 1 DM, and presented later to the diabetes service.Conclusions Perinatal mortality in Type 2 DM is signi®cantly increased, mainly owing to an excess of late fetal death. Maternal factors such as obesity may be important contributors to the high perinatal mortality. Women diagnosed with GDM who have unrecognized Type 2 DM are also at high risk, but perinatal mortality is low in women with milder degrees of glucose intolerance in pregnancy.
OBJECTIVE -Women with type 2 and type 1 diabetes have differing risk factors for pregnancy loss. We compared the rates and causes of pregnancy loss in women with type 1 and type 2 diabetes.RESEARCH DESIGN AND METHODS -We utilized prospectively collected data on all pregnancies in a 20-year period (1986 -2005) from a single center with a high prevalence of type 2 diabetes. Pregnancy losses included terminations for medical reasons and deaths up to 1 month postpartum but not spontaneous pregnancy losses Ͻ20 weeks' gestation.RESULTS -There were 870 pregnancies in women with known diabetes (330 with type 1 and 540 with type 2 diabetes) and 325 in women with diabetes diagnosed in pregnancy but persisting postpartum (97% type 2 diabetes). The rate of pregnancy loss was similar in type 1 and type 2 diabetes (2.6 vs. 3.7%, P ϭ 0.39), but the causes of pregnancy loss differed. In type 1 diabetes Ͼ75% were attributable to major congenital anomalies or prematurity; in type 2 diabetes Ͼ75% were attributable to stillbirth or chorioamnionitis (P ϭ 0.017). Women with type 2 and type 1 diabetes had similar A1C at presentation and near term, but the former were older (P Ͻ 0.001) and more obese (P Ͻ 0.0001).CONCLUSIONS -There are significant differences in the main causes of pregnancy loss in women with type 1 and type 2 diabetes. The higher rates of stillbirth in women with type 2 diabetes, suggest that other features, such as obesity, contribute significantly to pregnancy losses. Diabetes Care 30:2603-2607, 2007B efore the discovery of insulin, a woman with type 1 diabetes had almost no chance of successful delivery of a healthy baby. With the advent of insulin treatment, pregnancy losses continued to be high, predominantly through stillbirth, but neonatal deaths due to congenital malformation, birth trauma, hypoglycemia, and respiratory distress syndrome all took their toll (1). Substantial improvement in the rates of perinatal mortality followed the development of centralized care and regimens focused on achieving strict glycemic control and ensuring early delivery (2,3). Several centers have reported stillbirth rates in women with type 1 diabetes that are comparable to those in nondiabetic women (4 -7). Pregnancy losses due to congenital anomalies (resulting from poor glycemic control in early pregnancy) have proven harder to reduce, so terminations of pregnancy or neonatal death resulting from severe congenital anomalies now account for a large proportion of pregnancy losses in women with type 1 diabetes (6,8,9).The developing epidemic of obesity over the last two decades has seen a substantial reduction in the age of onset of type 2 diabetes and its emergence in women of childbearing age. In many areas of the world, the number of pregnancies in women with type 2 diabetes now exceeds that of women with type 1 diabetes (6,10 -13). A number of centers have reported higher rates of stillbirth or congenital anomalies in type 2 diabetic pregnancy, suggesting that the outcomes of pregnancy in type 2 diabetes can be worse than tha...
No abstract
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.